Cell & Bioscience
Cure8 research brief
Why This Matters
The study suggests a specific macrophage pathway (TRPV1→miR‑31/Wnt16) by which high‑fat diets may worsen intestinal inflammation and fibrosis, offering possible targets for future IBD research relevant to patients with metabolic comorbidities.
Who Should Pay Attention
Researchers in IBD pathogenesis, translational scientists, clinicians focused on IBD and fibrosis, and patients/researchers interested in diet‑IBD interactions.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The paper is a laboratory (mouse and cell) study exploring mechanisms by which a high‑fat diet and reduced TRPV1 in macrophages can worsen colitis. It is not a clinical trial or human intervention study.
The findings point to a specific molecular pathway (miR‑31/Wnt16 and non‑canonical Wnt signaling) that could explain diet‑related worsening of intestinal inflammation and fibrosis; these are potential targets for future research but are not yet therapies.
Keep In Mind
Findings come from mouse models and cell experiments; they identify mechanisms and potential targets but do not provide clinical evidence or treatment recommendations.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationCell & Bioscience
PublisherSpringer Science and Business Media LLC
AuthorsXiaodong Yan, Biao Zheng, Qi Zhang +9 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedSep 28, 2026, 12:00 AM
Content availableJournal abstract
Funding disclosed by the source: National Natural Science Foundation of China, award 32300601; National Natural Science Foundation of China, award U23A20399; National Natural Science Foundation of China, award 32071130; Shandong Provincial Natural Science Foundation, award ZR2023QH056; Beijing Natural Science Foundation, award 5232004; School of Basic Medical Sciences, Capital Medical University, award CMU-CGT26C06
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Microbial metabolite hyodeoxycholic acid induces macrophage immunometabolic reprogramming and alleviates ulcerative colitis.
The work links a missing bacterial metabolite (HDCA) to macrophage metabolism and reduced intestinal inflammation in experimental models, highlighting a potential microbiome-derived pathway that could be targeted for...
Single-cell transcriptomic analysis reveals that Trametes robiniophila Murr. (Huaier) granules protect against ulcerative colitis by targeting macrophage-associated cGAS-STING signaling.
The study describes a mechanism by which Huaier granules reduced colitis-related inflammation in mice and cell models by targeting macrophage cGAS–STING signaling and altering the gut microbiome—information that could...
Fusobacterium nucleatum-derived succinic acid aggravates colitis by triggering macrophage pro-inflammatory phenotypic transformation via SUCNR1/NF-κB axis.
The paper identifies a specific bacterial metabolite-receptor pathway (succinic acid → SUCNR1 → NF-κB) by which Fusobacterium nucleatum may worsen intestinal inflammation, suggesting new targets for IBD research and...